Home Health & Hospice Deal Flow Is Slow but Steady

Home Health & Hospice Deal Flow Is Slow but Steady

Although Covid-19 has brought the U.S. economy to a halt over the past few weeks, there is still some healthcare M&A activity to be found, even in the Home Health & Hospice sector. So far for the first quarter, 16 deals have been made public, compared with 21 for Q1: 2019, according to our Deal Search Online database. It’s a 27% drop, but that’s a difference of five deals in extraordinarily different market conditions. We’ll take what we can get. Earlier in March, Charter Health Care Group, a portfolio company of Pharos Capital Group, acquired two hospice service providers from VeraCare Hospice, St. Luke’s Home Hospice LLC and Arizona Select Hospice LLC. St.... Read More »
Hot Healthcare Sectors for Investment, Growth & Consolidation in 2020

Hot Healthcare Sectors for Investment, Growth & Consolidation in 2020

Every year, starting in November, the crystal balls come out and the prognostications begin. What will the new year bring? Who or what will make out better and who or what will not? We talked with Gary Herschman, a member of Epstein Becker Green’s Healthcare and Life Sciences practice, about the healthcare sectors he and his firm are watching in 2020. Here are their predictions for 2020. Health Care M&A: What do you see as the biggest themes in the healthcare industry this year? There are a lot of moving parts, from the discovery of new drugs to the shifting attention to post-acute care. Gary Herschman: We see three key “drivers” of health industry transformation that are already... Read More »
Aveanna Healthcare Calls Off Maxim Home Health Merger

Aveanna Healthcare Calls Off Maxim Home Health Merger

The Federal Trade Commission has done it again. The agency closed its investigation into the merger of Aveanna Healthcare with Maxim Healthcare’s home health division, announced in February 2019. We’re accustomed to seeing headlines every few months saying the FTC plans to tighten scrutiny of hospital mergers and acquisitions. The anti-trust division has been active in the hospital sector, the majority of announced hospital mergers more often collapse under their own, unique conditions. Just last year, Care New England ended merger talks with Lifespan and Brown University, after seeing its merger with Boston’s Partners HealthCare shot down by Rhode Island’s... Read More »
Ensign Group Spin-Off Makes Another Deal

Ensign Group Spin-Off Makes Another Deal

In October 2019, The Ensign Group (NASDAQ: ENSG) and The Pennant Group, Inc. (NASDAQ: PNTG) announced the completion of Pennant’s spin-off. The two separated to give investors more and better industry-specific options; The Ensign Group will stay focused on services ranging from skilled nursing to various forms of therapy and rehab, while The Pennant Group will operate in the home health and hospice and senior living markets. The latter is comprised of two of Ensign’s former subsidiaries, Cornerstone Health and Pinnacle Senior Living. And now in early 2020, The Pennant Group is keeping its promise and wasting no time to expand. In early January, Cornerstone Healthcare acquired... Read More »
Arosa+LivHOME Bets On New Care Management Platform

Arosa+LivHOME Bets On New Care Management Platform

Arosa+LivHOME is already on the acquisition trail in the new year. According to our Deal Search Online database, the company reported six transactions in 2019 and is wasting no time to keep growing. In early January, the Bain Capital Double Impact portfolio company purchased Lifecare Innovations, a professional care management services provider. No financial details were disclosed. The acquisition is a step into the care management (CM) market, a growing field in the home health sector. CM aims to help patients navigate the healthcare system and treatment options for disabilities, disease and age-related issues, and with the advent of value-based incentives from CMS, some firms are... Read More »
2019’s Biggest Healthcare Deals, by Sector

2019’s Biggest Healthcare Deals, by Sector

2020 has just begun, which means it’s time to look back at the healthcare M&A landscape of 2019. Just three days into the new year, nearly 1,780 deals are already on the books for 2019. More deals will turn up as we search our many sources, but the number likely won’t top the record of 1,900-plus set in 2018. Thanks to the multi-billion-dollar deals announced in the Biotech and Pharmaceutical sectors, 2019 will set a new spending record. Preliminary data show $399.1 billion was spent on healthcare acquisitions last year, about 20% higher than in 2018. We expect that number to rise as we go through the year and the 10Ks and quarterly reports come out. It’s possible the... Read More »